August 2010

The dispensing rate for generic statins is expected to rise slowly due to increased volumes of simvastatin and pravastatin sodium moderated by increased Crestor volumes.

Improving patient engagement in healthcare decisions is essential for achieving positive, measurable health goals, including lowering overall healthcare costs.

The effectiveness of ezetimibe monotherapy for lowering low-density lipoprotein cholesterol was assessed in a managed care population.

This prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.

Investment in prevention and treatment of cardiovascular disease must consider overall effect on employee health and productivity, not exclusively direct health coverage costs.

Pharmacy benefit managers can aid both physicians and employers in providing quality healthcare at an affordable price.

As the number of both generic and specialized products continues to increase, we must seek a clear method for defining value in healthcare delivery.

We need to get serious about programs to control hypertension.